公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009 | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Lam C.; Chen R.-J. | International Journal of Antimicrobial Agents | 25 | 25 | |
2015 | Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009 | Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 5 | 7 | |
2015 | Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options | Jean S.-S.; Lee W.-S.; Lam C.; Hsu C.-W.; Chen R.-J.; PO-REN HSUEH | Future Microbiology | 94 | 84 | |
2017 | Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295] (S0732889314004076)(10.1016/j.diagmicrobio.2014.09.027) | Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 0 | 0 | |
2018 | Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008)) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 4 | 2 | |
2004 | Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan | NAI-KUAN CHOU ; Chen R.-J.; Ko W.-J.; Lin H.-L.; Yu S.-Y.; YIH-SHARNG CHEN ; RON-BIN HSU ; CHII-MING LEE ; Lin F.-Y.; SHOEI-SHEN WANG | Transplantation Proceedings | 6 | 6 | |
1998 | Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections | JIA-HORNG KAO ; Chen R.-J.; Lai M.-Y.; Chen W.; DING-SHINN CHEN | Archives of Virology | 16 | 13 | |
1998 | EQCM Studies of Paraquat on Gold Electrode Modified with Electropolymerized Film | Chang H.-C.; TZONG-JIH CHENG ; Chen R.-J. | Electroanalysis | | | |
2001 | Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells | Ho Y.-S.; Duh J.-S.; JIIANG-HUEI JENG ; Wang Y.-J.; Liang Y.-C.; Lin C.-H.; Tseng C.-J.; Yu C.-F.; Chen R.-J.; Lin J.-K. | International Journal of Cancer | 125 | | |
2003 | In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest | Lee W.-S.; Chen R.-J.; Wang Y.-J.; Tseng H.; JIIANG-HUEI JENG ; Lin S.-Y.; Liang Y.-C.; Chen C.-H.; Lin C.-H.; Lin J.-K.; Ho P.-Y.; Chu J.-S.; Ho W.-L.; Chen L.-C.; Ho Y.-S. | International Journal of Cancer | 70 | 64 | |
1999 | Induction of apoptosis by S-nitrosoglutathione and Cu2+ or Ni2+ ion through modulation of bax, bad, and bcl-2 proteins in human colon adenocarcinoma cells | Ho Y.-S.; Liu H.-L.; Duh J.-S.; Chen R.-J.; Ho W.-L.; JIIANG-HUEI JENG ; Wang Y.-J.; Lin J.-K. | Molecular Carcinogenesis | 29 | | |
2002 | Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice | Wang Y.-J.; JIIANG-HUEI JENG ; Chen R.-J.; Tseng H.; Chen L.-C.; Liang Y.-C.; Lin C.-H.; Chen C.-H.; Chu J.-S.; Ho W.-L.; Ho Y.-S. | Molecular Carcinogenesis | 20 | 21 | |
2016 | Leclercia adecarboxylata bacteremia in a patient with long-term use of nonsteroidal anti-inflammatory drugs | Jean S.-S.; Lee W.-S.; Bai K.-J.; Lam C.; Hsu C.-W.; Chen R.-J.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 11 | 8 | |
2016 | Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 20 | 15 | |
2015 | Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007 | Jean S.-S.; Lee W.-S.; Bai K.-J.; Lam C.; Hsu C.-W.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 12 | 9 | |
2005 | Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFκB activation and cyclin D1 up-regulation | Ho Y.-S.; Chen C.-H.; Wang Y.-J.; Pestell R.G.; Albanese C.; Chen R.-J.; Chang M.-C.; JIIANG-HUEI JENG ; Lin S.-Y.; Liang Y.-C.; Tseng H.; Lee W.-S.; Lin J.-K.; Chu J.-S.; Chen L.-C.; Lee C.-H.; Tso W.-L.; Lai Y.-C.; Wu C.-H. | Toxicology and Applied Pharmacology | 103 | 88 | |